Updated Jul 16, 2026
Shiver John W. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

John W. Shiver is a corporate director associated with Novavax Inc, a biotechnology company focused on developing vaccines. His specific contributions and background details are not widely documented in public sources.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-12 | NVAX | NOVAVAX INC | M — Option exercise | 7.9K | $0.00 |
John W. Shiver is a corporate director associated with Novavax Inc, a biotechnology company focused on developing vaccines. His specific contributions and background details are not widely documented in public sources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shiver John W. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.